What medication and treatment adjustments should be made for a 36-year-old man with chronic depression, generalized anxiety disorder, post‑traumatic stress disorder, attention‑deficit/hyperactivity disorder, and panic attacks, who is currently taking venlafaxine, sertraline, aripiprazole, mirtazapine, lamotrigine, gabapentin, uses marijuana three to four times weekly, consumes six to ten alcoholic drinks per week, and continues to feel depressed, irritable, and anxious?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Optimize Current Medication Regimen and Address Substance Use

Your patient requires immediate medication optimization: increase lamotrigine to a therapeutic dose (200-400 mg daily), discontinue mirtazapine due to redundancy with sertraline, taper gabapentin as it lacks evidence for his conditions, and critically address his alcohol and marijuana use which are significantly undermining treatment efficacy. 1

Critical Issues Requiring Immediate Attention

Substance Use is Sabotaging Treatment

Your patient's 6-10 alcoholic drinks weekly and marijuana use 3-4 times weekly are directly interfering with antidepressant efficacy and worsening anxiety/depression symptoms. Alcohol is a CNS depressant that:

  • Disrupts serotonin and norepinephrine systems that antidepressants target
  • Worsens depression and anxiety between drinking episodes
  • Reduces SSRI/SNRI effectiveness 2, 3

Action: Directly address alcohol reduction as a treatment priority. SSRIs like sertraline can paradoxically increase alcohol consumption in actively drinking patients 3. Consider adding gabapentin 300-600mg TID specifically for alcohol use disorder if he cannot reduce intake, as it has evidence for both anxiety and alcohol dependence 4, 3.

Polypharmacy Without Clear Rationale

He's taking sertraline 75mg (low-moderate dose), mirtazapine 15mg, lamotrigine 100mg, and gabapentin 600mg PRN—this represents irrational polypharmacy:

Medication Optimization Algorithm:

  1. Lamotrigine (currently 100mg): This is subtherapeutic for mood stabilization

    • Increase to 200mg daily over 2-4 weeks, then assess
    • Target dose: 200-400mg daily for bipolar depression/mood instability 5
    • This addresses his irritability, mood lability, and treatment-resistant depression

  2. Sertraline (currently 75mg): Suboptimal dosing

    • Increase to 150-200mg daily (maximum 200mg) 6
    • At 75mg, he's below the typical therapeutic range for depression/anxiety
    • Monitor for 6-8 weeks at therapeutic dose before declaring treatment failure 1

  3. Mirtazapine (currently 15mg): Discontinue

    • No evidence for combining with SSRIs in his presentation
    • The 15mg dose is primarily sedating without significant antidepressant effect
    • Creates unnecessary polypharmacy and potential drug interactions 7, 8
    • If insomnia persists after discontinuation, address with CBT for insomnia, not additional medication

  4. Gabapentin (currently 600mg PRN): Reassess indication

    • No strong evidence for depression, PTSD, or generalized anxiety as monotherapy
    • Either: Discontinue if alcohol use is controlled, OR
    • Convert to: 300-600mg TID scheduled dosing specifically for alcohol use disorder 4, 3

Second-Line Augmentation Strategy

If symptoms persist after 6-8 weeks at optimized doses (sertraline 200mg + lamotrigine 200-400mg):

Add aripiprazole 2-5mg daily as augmentation 9, 10

  • Start 2mg daily, increase to 5mg after 1 week if tolerated
  • Evidence supports augmentation for treatment-resistant depression and anxiety 10
  • Monitor for akathisia (restlessness), which can mimic anxiety
  • He's already familiar with aripiprazole from prior regimen

Addressing His Specific Symptom Clusters

Depression + Anxiety + Irritability

This triad suggests:

  • Inadequate SSRI dosing (sertraline 75mg is insufficient)
  • Possible bipolar spectrum disorder (family history of depression, irritability, mood lability)
  • Lamotrigine at therapeutic doses specifically targets irritability and mood instability 5

PTSD Symptoms

  • Sertraline is first-line for PTSD 3, 11, 12
  • Current 75mg dose is inadequate; increase to 150-200mg
  • Prazosin 1-6mg at bedtime can be added specifically for PTSD nightmares if present (not mentioned in evidence but standard practice)

Work-Related Anxiety and Childhood Trauma

  • His anxiety around authority figures (boss) and unresolved anger toward father require trauma-focused psychotherapy
  • Continue CBT but ensure it's trauma-focused CBT or EMDR specifically for PTSD 12
  • Medication alone is insufficient for trauma processing

Monitoring and Follow-Up Timeline

Week 1-2:

  • Assess alcohol/marijuana use patterns
  • Begin lamotrigine increase (25-50mg increments weekly)
  • Taper mirtazapine over 1-2 weeks
  • Increase sertraline to 100mg

Week 3-4:

  • Continue lamotrigine titration toward 200mg
  • Increase sertraline to 150mg
  • Reassess substance use

Week 6-8:

  • Sertraline at 200mg, lamotrigine at 200mg minimum
  • Formal assessment of response using PHQ-9 and GAD-7 scores
  • If inadequate response: increase lamotrigine to 300-400mg OR add aripiprazole 2-5mg

Week 12:

  • If still inadequate response with optimized doses + aripiprazole: consider switching strategies (venlafaxine XR 150-225mg as alternative SNRI) 1

Critical Warnings

Serotonin Syndrome Risk

Combining sertraline with mirtazapine increases risk. Discontinuing mirtazapine reduces this risk. Watch for: agitation, confusion, tremor, tachycardia, diaphoresis 13, 7

Suicidality Monitoring

He reports passive death wishes and uncontrollable crying. With medication changes, monitor weekly for first month for worsening suicidal ideation, especially given his age (36) and antidepressant adjustments 6, 7, 9

Lamotrigine Rash

When increasing lamotrigine, educate about Stevens-Johnson syndrome risk. Any rash = immediate discontinuation and emergency evaluation 5

What NOT to Do

  • Don't add benzodiazepines: High addiction potential, especially with his alcohol use and family history
  • Don't continue ineffective polypharmacy: Mirtazapine + sertraline has no evidence base here
  • Don't ignore substance use: Treatment will fail if alcohol/marijuana use continues unchecked
  • Don't switch antidepressants prematurely: He hasn't had an adequate trial of sertraline at therapeutic doses (needs 150-200mg for 6-8 weeks) 1

References

2
Research

Pharmacotherapy for anxiety and comorbid alcohol use disorders.

The Cochrane database of systematic reviews, 2015

12
Research

Posttraumatic Stress Disorder and Anxiety-Related Conditions.

Continuum (Minneapolis, Minn.), 2021

13
Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Related Questions

What is the recommended management for a 43‑year‑old female with a history of depression, anxiety, post‑traumatic stress disorder, and asthma who presents with worsening morning panic attacks, and is the use of a paper‑bag breathing technique appropriate?
In a 77-year-old patient with depressed mood who is currently taking mirtazapine 7.5 mg at bedtime and reports a history of military PTSD without a documented diagnosis, should I initiate escitalopram (Lexapro) 5 mg?
In a 35‑year‑old woman with post‑traumatic stress disorder, anxiety disorder, depressive disorder, severe opioid (oxycodone) and benzodiazepine (alprazolam) use disorders admitted to short‑term residential rehabilitation, should gabapentin be increased from 300 mg twice daily to her home dose of 600 mg three times daily?
In a 38-year-old man with alcohol use disorder, a history of pancreatitis, depression and anxiety, normal renal function, mildly elevated alanine aminotransferase, moderately elevated aspartate aminotransferase, elevated lipase, normal thyroid‑stimulating hormone, and a borderline prolonged QTc of 470 ms, who is taking escitalopram 10 mg daily (Lexapro) and buspirone, are these medications safe?
What is the most appropriate medication regimen for treating generalized anxiety disorder, major depressive disorder, obsessive‑compulsive disorder, insomnia, and post‑traumatic stress disorder?
In a 78-year-old woman with pulmonary emboli on rivaroxaban and rheumatoid arthritis on methotrexate who developed a severe pruritic eczema-like rash after starting omeprazole (and pantoprazole), with negative pemphigoid antibodies and biopsy showing excoriation, what is the optimal management of this drug‑induced dermatitis?
What are the newest FDA‑approved medications for attention‑deficit/hyperactivity disorder, what level of evidence supports them, and what are the recommended dosing and usage guidelines?
Should a 52-year-old man with LDL cholesterol 3.03 mmol/L, HDL cholesterol 1.34 mmol/L, and lipoprotein(a) 172 nmol/L be started on a statin?
How long should a patient with vitamin B12 deficiency take a B‑complex supplement?
How should a patient with a vitamin B12 level of 163 pg/mL be evaluated and treated?
Does rivastigmine help with anxiety in an older adult with dementia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.